| 논문분류 | 춘계학술대회 초록집 |
|---|---|
| 제목 | Periostin-binding DNA aptamer ameliorates peritoneal dialysis-induced peritoneal fibrosis |
| 저자 | Bo Young Nam* 1, Meiyan Wu1, Ji Min Park1, Jae Eun Um1, Seonghun Kim1, Hye-Young Kang1, Seohyun Park2, Su-Young Jung2, Jong Hyun Jhee2, Hae-Ryong Yun2, Hyoungnae Kim2, Youn Kyung Kee2, Chang-Yun Yoon2, Young Eun Kwon2, Jung Tak Park2, Seung Hyeok Han2, Ta |
| 출판정보 | 2016; 2016(1): |
| 키워드 | Aptamer, Epithelial-mesenchymal transition, Periostin, Peritoneal dialysis, Peritoneal fibrosis, Transforming growth factor-β1 |
| 초록 | Background: Peritoneal fibrosis (PF) is a major complication, leading to ultrafiltration failure in patients on peritoneal dialysis (PD). In PD-related PF, the protein expressions of various extracellular matrix including periostin are known to be increased via the transforming growth factor-β1 (TGF-β1) pathway. This study was undertaken to evaluate the impact of periostin inhibition by novel aptamer-based inhibitor on TGF-β1-induced epithelial-mesenchymal transition (EMT) in cultured human peritoneal mesothelial cells (HPMCs) and in an animal model of PD. Methods: In vitro, primary HPMCs were exposed to TGF-β1 (2 ng/ml) to induce EMT and fibrosis with or without periostin siRNA (100 nM) or periostin-binding DNA aptamer (200 nmol/l). In vivo, PD catheters were inserted into 48 C57BL/6 mice, and saline (C group, N=24) or 4.25% PD solution (PD group, N=24) was infused for 4 weeks. Twelve mice from each group were treated with periostin-binding DNA aptamer (500 μg/kg/d) (PA). mRNA and protein expressions of periostin, fibronectin, α-smooth muscle actin (α-SMA), snail, and E-cadherin in HPMCs and mouse peritoneum were evaluated by quantitative real-time polymerase chain reaction and western blot analysis, respectively. PF was also assessed by Masson’s trichrome (MT) staining. Results: In vitro, TGF-β1 treatment significantly up-regulated periostin, fibronectin, α-SMA, and snail expressions, while E-cadherin expression was significantly decreased by TGF-β1 in cultured HPMCs (P < 0.01). Not only periostin siRNA but also periostin-binding DNA aptamer significantly attenuated TGF-β1-induced periostin, fibronectin, α-SMA, and snail expressions and significantly restored E-cadherin expression in HPMCs (P < 0.05). In vivo, the expressions of periostin, fibronectin, α-SMA, and snail were significantly increased, whereas E-cadherin expression was significantly decreased in the peritoneum of PD mice (P < 0.05). The thickness of the submesothelial layer and the intensity of MT staining in the peritoneum were significantly higher in PD mice compared to C mice (P < 0.05). These changes in the PD group were significantly abrogated by PA treatment (P < 0.05). Conclusion: These findings suggest that PA can be a potential therapeutic strategy for PF in PD patients. |
| 원문(PDF) | PDF 원문보기 |